Home
Conditions
Graft-Versus-Host Disease

Clinical trial condition

Graft-Versus-Host Disease

Explore clinical trials studying Graft-Versus-Host Disease. Study availability and eligibility vary by location and protocol.

53 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Graft-Versus-Host Disease trial results

Completed

A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea

NCT05621733

Conditions: Graft vs Host Disease, Graft-Versus-Host Disease, Immune System Diseases
Locations: Novartis Investigative Site Daegu, Dalseo gu, South Korea

Novartis Investigative Site Wŏnju, Gangwon-do, South Korea

Novartis Investigative Site Uijeongbu-si, Gyeonggi-do, South Korea

Novartis Investigative Site Jinju, Gyeongsangnam-do, South Korea

View all 14 locations

View Trial Details

Completed

Pomalidomide for Chronic Graft-versus-Host Disease

NCT01688466

Conditions: Graft vs Host Disease, Graft-Versus-Host Disease, Immune System Diseases
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Prevention of GVHD in Patients Treated With Allogeneic SCT: Possible Role of Extracorporeal Photophoresis

NCT03204721

Conditions: Graft vs Host Disease, Graft-Versus-Host Disease, Immune System Diseases
Locations: Tobias Gedde-Dhl Oslo, Norway

View Trial Details

Completed

Study on the Safety and Effectiveness of VELCADE® in the Treatment of Graft-Versus-Host Disease

NCT00408928

Conditions: Graft vs Host Disease, Graft-Versus-Host Disease, Immune System Diseases
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Measurements of Resting Energy Expenditure in Patients With or at Risk of Developing Graft Versus Host Disease

NCT00600314

Conditions: Graft vs Host Disease, Graft-Versus-Host Disease, Immune System Diseases, +5 more
Locations: Children's Memorial Hospital Chicago, Illinois, United States

View Trial Details

Completed

Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation

NCT02342613

Conditions: Graft vs Host Disease, Graft-Versus-Host Disease, Hematologic Diseases, +6 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention

NCT04503616

Conditions: Graft vs Host Disease, Graft-Versus-Host Disease, Immune System Diseases
Locations: NYU Langone Health New York, United States

View Trial Details

Completed

Neihulizumab for Standard-Risk Acute Graft Versus Host Disease (GVHD)

NCT04144036

Conditions: Graft vs Host Disease, Graft-Versus-Host Disease, Immune System Diseases
Locations: Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

To Assess SHR0302 Oral Solutions and Tablets in Healthy Subjects Clinical Studies of Relative Bioavailability

NCT05856058

Conditions: Graft vs Host Disease, Graft-Versus-Host Disease, Immune System Diseases
Locations: Beijing Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT

NCT02942173

Conditions: Bone Marrow Diseases, GVHD, Graft vs Host Disease, +14 more
Locations: Federal Research Center for pediatric hematology, oncology and immunology Moscow, Russia

View Trial Details

Graft-Versus-Host Disease

Graft-Versus-Host Disease trial results

Related conditions